These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

57 related items for PubMed ID: 7741408

  • 21. Ultrarapid metabolism of clomipramine in a therapy-resistant depressive patient, as confirmed by CYP2 D6 genotyping.
    Baumann P, Broly F, Kosel M, Eap CB.
    Pharmacopsychiatry; 1998 Mar; 31(2):72. PubMed ID: 9562213
    [No Abstract] [Full Text] [Related]

  • 22. Differential foetal development of the O- and N-demethylation of codeine and dextromethorphan in man.
    Ladona MG, Lindström B, Thyr C, Dun-Ren P, Rane A.
    Br J Clin Pharmacol; 1991 Sep; 32(3):295-302. PubMed ID: 1838002
    [Abstract] [Full Text] [Related]

  • 23. Theoretical investigation of substrate specificity for cytochromes P450 IA2, P450 IID6 and P450 IIIA4.
    De Rienzo F, Fanelli F, Menziani MC, De Benedetti PG.
    J Comput Aided Mol Des; 2000 Jan; 14(1):93-116. PubMed ID: 10702928
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Cola and cough syrup used to determine abnormal drug metabolism.
    Oncology (Williston Park); 1989 Nov; 3(11):111-2. PubMed ID: 2641308
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Bladder cancer recurrence and its association with cytochrome P-450IID6 activity.
    Persad RA, Fleming CM, Wilkinson GR, Smith PJ, Branch RA.
    Prog Clin Biol Res; 1992 Nov; 378():19-27. PubMed ID: 1301581
    [No Abstract] [Full Text] [Related]

  • 28. Concordance of phenotype and genotype for CYP2D6.
    McLeod HL.
    Clin Pharmacol Ther; 1994 Oct; 56(4):463-4. PubMed ID: 7955809
    [No Abstract] [Full Text] [Related]

  • 29. Regulation of cytochrome P450 IID by acute phase mediators in C3H/HeJ mice.
    Trautwein C, Ramadori G, Gerken G, Meyer zum Büschenfelde KH, Manns M.
    Biochem Biophys Res Commun; 1992 Jan 31; 182(2):617-23. PubMed ID: 1370887
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. [Functional status of the cytochrome P-450-dependent monooxygenase system in multiple sclerosis and amyotrophic lateral sclerosis].
    Zavalishin IA, Kovaleva VL, Evsta'feva OL, Niiazbekova AS, Mzhe'lskaia TI.
    Sov Med; 1989 Jan 31; (5):106-8. PubMed ID: 2781367
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Molecular genetics of cytochrome P450 IID. Anomalies of drug metabolism.
    Jacqz-Aigrain E, Panserat S, Sica L, Krishnamoorthy R.
    Clin Rev Allergy Immunol; 1995 Jan 31; 13(3):211-21. PubMed ID: 8535928
    [No Abstract] [Full Text] [Related]

  • 34. The effects of dimethylsulphoxide and 5-aminolaevulinic acid on the activities of cytochrome P450-dependent mixed function oxidase and UDP-glucuronosyl transferase activities in human Hep G2 hepatoma cells.
    Doostdar H, Burke MD, Melvin WT, Grant MH.
    Biochem Pharmacol; 1991 Aug 22; 42(6):1307-13. PubMed ID: 1653569
    [No Abstract] [Full Text] [Related]

  • 35. Codeine metabolism in three Oriental populations: a pilot study in Chinese, Japanese and Koreans.
    Yue QY, Svensson JO, Säwe J, Bertilsson L.
    Pharmacogenetics; 1995 Jun 22; 5(3):173-7. PubMed ID: 7550369
    [No Abstract] [Full Text] [Related]

  • 36. Genotypes of cytochrome P450 and clinical response to clomipramine in patients with major depression.
    Bouchez J, Dumur V, Lhermitte M, Goudemand M.
    Eur Psychiatry; 1995 Jun 22; 10(8):410-2. PubMed ID: 19698378
    [Abstract] [Full Text] [Related]

  • 37. Influence of amesergide treatment on the dextromethorphan test.
    Baumann P, Hatzinger M, Hemmeter U, Seifritz E, Eap CB, Holsboer E.
    Br J Clin Pharmacol; 1994 Aug 22; 38(2):151-2. PubMed ID: 7981017
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Cytochrome P450 2D6 poor metabolism, curvilinearity, and response: an intriguing observation requiring integration of psychopharmacology into pharmacogenetics.
    Al Hadithy AF, Birkenhager TK, Koch BC.
    J Clin Psychopharmacol; 2013 Dec 22; 33(6):833-4. PubMed ID: 24196656
    [No Abstract] [Full Text] [Related]

  • 40. Effects of phenelzine and acetylator phenotype.
    Rowan PR, Paykel ES, West PS, Rao BM, Taylor CN.
    Neuropharmacology; 1981 Dec 22; 20(12B):1353-4. PubMed ID: 7322308
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 3.